Skip to main content
. 2021 Jun 3;11:11736. doi: 10.1038/s41598-021-91195-2

Figure 3.

Figure 3

Microbiome composition of NSCLC patients and non-cancer controls in bronchoscopy samples. (A) Taxonomic composition of non-human sequences at phylum level in NSCLC patients and non-cancer controls in bronchoscopy samples. (B) The Shannon diversity index between NSCLC patients and non-cancer controls in bronchoscopy samples. Difference between sampling methods was determined by Student t test. *p < 0.05. (C) PCoA analysis of NSCLC patients and non-cancer controls in bronchoscopy samples. (D) The differential species between NSCLC patients and non-cancer controls in bronchoscopy samples were identified by Wilcoxon rank-sum test (p < 0.05). N non-cancer controls, T NSCLC patients.